Descripción y análisis del funcionamiento del programa de cesación tabáquica de la obra social universitaria (DASPU) período enero 2017- mayo 2019

Title: Description and analysis of the performance of the smoking cessation program of the university’s health insurance (DASPU) in the time period between January 2017 and May 2019. Introduction: The health insurance (DASPU) offers an engaging program for people who wish to quit smoking. Said program is based on a comprehensive health care strategy promoted by DASPU, fulfilling the responsibility of bringing forth areas of prevention for common chronic illnesses. Objective: Describe and analyze the performance of the smoking cessation program of the health insurance in the time period between 2017-2019 Materials and methods: The primary data source used were the records designed (ad hoc) for the program with the objective of realizing future evaluations. The variables used correspond to two units of analysis: a) the program and b) the patient The variables related to the patient are: Sex Age Pack-year index Type of treatment (varenicline, bupropion, nicotine, non-pharmacological, conduct cognitive therapy) Smoking cessation rate For all the variables the methodology used was quantitative and descriptive, while for the analysis of the program’s efficacy the cessation rate expressed in percentage was used. Results: The percentage increase of professionals trained in this period was 50%, 92% of them completed all the records; the number of patients increased from 6-217. Of all the patients 52% are women, the average age in years was 48.5 (59:21); the median pack-year index was 28.5(96:6); 23(10.6%) of patients used bupropion, 94(43.3%) used varenicline, 30 (13.8%) used nicotine, 47 (21.6%) used a combination of drugs and 23 (10.6%) were approached with a non-pharmacological approach. The cessation rate was 18%. Conclusion: The program’s performance reaches the proposed objectives, the cessation rate achieved acceptable values for a program that started recently, it’ necessary to reinforce some of the follow-up actions with patients, the economical and quality of life benefits can be measured from here on forward.